ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

SLPI in the Perfusion Liquid: A Predictor Marker of Short and Long Term Clinical Outcomes.

A. Dotta,1 F. Caro,2 K. Peña Ponce,1 N. Ambrosi,2 J. Salaberry,2 X. García,1 E. Minué,1 L. León,1 F. Sánchez,2 F. Togniolo,1 C. Incardona,3 E. Chuluyan,2 D. Casadei.1

1Instituto de Nefrología, Caba, Argentina
2CEFYBO-UBA, Caba, Argentina
3Fundación GADOR, Caba, Argentina.

Meeting: 2016 American Transplant Congress

Abstract number: 498

Keywords: Donors, Ischemia, Kidney transplantation, marginal, Preservation solutions

Session Information

Date: Tuesday, June 14, 2016

Session Name: Concurrent Session: Ischemia Reperfusion Injury: Clinical Innovation

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 311

Related Abstracts
  • Inhibition of mTOR Modulates SLPI Expression: A Potential Role in Kidney Transplant Patients
  • Short, Cool and Well Oxygenated – HOPE for DCD Kidneys.

A lot of efforts have been done to identify the risk factors that tend to diminish the incidence of delayed graft function (DGF). Recently, the secretory leukocyte peptidase inhibitor (SLPI) was proposed as a biomarker candidate for acute kidney injury (AKI), since high level of it was found in plasma and urine of patients. The aim of the present work was to determine if the level of SLPI in the cold preservation solution could be a useful marker to predict early and late kidney function after transplantation.

Twenty three patients were enrolled. Kidneys were perfused with 1 liter of Wisconsin solution before the transplantation. The SLPI concentration was measured on two fractions of the perfused solution, i.e. the first 50 ml (SLPI-A) and the last 50 ml (SLPI-B). Direct correlations were found between SLPI-B and DGF risk factors (donor age, p=0.013; pre-ablation plasma creatinine values, p=0.047; cold ischemia time, p=0.01). Furthermore, the patients with DGF had statistically significant higher SLPI-B values compared with patients without DGF (Figure 1).

Also, we found an indirect correlation between SLPI-B and MDRD measured at patient discharge. Interestingly, patients (6) that suffered rejections during the first 6 months after transplantation, had higher values of SLPI-A and SLPI-B than patients without rejections.

Remarkably, we find a direct association between KDPI (a score that evaluate the quality of deceased-donor kidneys) and SLPI-B (r=0.55; p<0.005) (Figure 2B).

These results suggest that SLPI concentration in the perfusion liquid could be a good predictor marker for short and long term clinical outcomes in kidney transplantation.

CITATION INFORMATION: Dotta A, Caro F, Peña Ponce K, Ambrosi N, Salaberry J, García X, Minué E, León L, Sánchez F, Togniolo F, Incardona C, Chuluyan E, Casadei D. SLPI in the Perfusion Liquid: A Predictor Marker of Short and Long Term Clinical Outcomes. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Dotta A, Caro F, Ponce KPeña, Ambrosi N, Salaberry J, García X, Minué E, León L, Sánchez F, Togniolo F, Incardona C, Chuluyan E, Casadei D. SLPI in the Perfusion Liquid: A Predictor Marker of Short and Long Term Clinical Outcomes. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/slpi-in-the-perfusion-liquid-a-predictor-marker-of-short-and-long-term-clinical-outcomes/. Accessed March 4, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.